Company news
NovelStem International Corp. news in 2020
NovelStem International Corp.'s news releases, calls and decks from 2020, newest first.
NovelStem Increases NewStem Ownership to 33% as NewStem Preps for 1H'21 FDA Filing for Approval of Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; Initiates Process to Be Publicly Reporting...
December 1, 2020
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy & COVID-19 Resistance; Progress ID'ing Genetic Resistance to Addt'l Anti-Cancer Treatments
April 21, 2020